ANNEKE VAN SLOTEN: Open Payments
NPI 1285016139 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 24 payments from 16 companies in 2025. Trend: 2023 $538 · 2024 $291 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 2 | $125 |
| Medtronic, Inc. | 1 | $92 |
| Novo Nordisk Inc | 4 | $91 |
| Mannkind Corporation | 2 | $47 |
| Amgen Inc. | 2 | $43 |
| Sequel Med Tech, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| Dexcom, Inc. | 1 | $31 |
| Chiesi USA, Inc. | 1 | $29 |
| BETA BIONICS, INC. | 1 | $28 |
Products named: t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, Ozempic, AFREZZA, TEPEZZA, TWIIST, TALTZ, Dexcom G6 Transmitter.
Industry payments across WA — which companies pay providers there.
